Author Archive: AZBio

NASA Awards PADT and Penn State University a $375,000 Phase III STTR Research Grant

Posted on by
When we applied for a NASA Small Business Technology Transfer (STTR) grant with Arizona State University in 2018 we had high hopes around that the idea of developing simulation and manufacturing techniques that would allow engineers to mimic structures found in Nature. Today’s win of a rare Phase III grant from NASA exceeded those hopes and further showed the space agencies’ interest in the research that PADT, ASU, and now Penn State are engaged in.

Continue reading→

Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study

Posted on by

At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died

Merck Plans to Seek Emergency Use Authorization in the U.S. as Soon as Possible and to Submit Applications to Regulatory Agencies Worldwide

If Authorized, Molnupiravir Could be the First Oral Antiviral Medicine for COVID-19Continue reading→